Follow-The-Filings

ESLA Estrella Immunopharma

Estrella Immunopharma earnings company data as of 7:30 PM ET 8/20

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period · newest first · EPS & Rev stacked · nothing reported yet

Period Date Metric Estimate Actual Result
FY2026 Q2 13 Aug EPS
Rev

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 3.01
10-Q QUARTERLY REPORT
8-K 5.07
10-Q QUARTERLY REPORT
10-K/A AMENDMENT NO. 1 TO FORM 10-K
10-K ANNUAL REPORT
424B3 PROSPECTUS
S-1/A REGISTRATION STATEMENT
S-1/A REGISTRATION STATEMENT
8-K 3.01
424B5 PROSPECTUS SUPPLEMENT
8-K 1.01,3.02,7.01,9.01
S-1 REGISTRATION STATEMENT
8-K 8.01,9.01
10-Q QUARTERLY REPORT
8-K 8.01,9.01
8-K 8.01
8-K 5.02
10-Q QUARTERLY REPORT
8-K 3.01
8-K 8.01,9.01
8-K 1.01,3.02,8.01,9.01
8-K 8.01,9.01
10-Q QUARTERLY REPORT
8-K 3.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 4 rows shown

Filed Form Detail Links
4 Period Aug 25, 2026
4 Period Aug 18, 2026
4 Period Sep 11, 2025
4 Period Oct 30, 2024 · 2 forms

Consensus estimates · SEC filings remain the official record · not investment advice